Pricing
  1. JP-listed companies
  2. Euglena Co., Ltd.
  3. Financials
  4. Total current assets

Euglena Co., Ltd. (2931)

Market cap
¥57.8B
P/E ratio
Develops health foods, cosmetics, and biofuels using Euglena microalgae through proprietary large-scale cultivation technology across healthcare and sustainable energy markets.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal current assets (Million JPY)YoY (%)
Dec 31, 202533,437+8.33%
Dec 31, 202430,865+26.34%
Dec 31, 202324,431+24.05%
Dec 31, 202219,694-3.64%
Dec 31, 202120,438-12.74%
Sep 30, 202123,422+139.21%
Sep 30, 20209,792-12.45%
Sep 30, 201911,183+32.49%
Sep 30, 20188,441-20.67%
Sep 30, 201710,641-6.29%
Sep 30, 201611,355+31.95%
Sep 30, 20158,605+17.66%
Sep 30, 20147,314

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat